Deerfield Management Boosts Its Stake in OvaScience Inc (OVAS)

Deerfield Management, led by James E. Flynn, revealed in a filing with the Securities and Exchange Commission that it has upped its stake in OvaScience Inc (NASDAQ:OVAS) to 1.8 million shares from 605,600 shares held at the end of the fourth quarter of 2013. The current passive stake amasses 7.6% of the company’s common stock.

OvaScience Inc (NASDAQ:OVAS)

OvaScience Inc (NASDAQ:OVAS) is a global life sciences company that discovers, develops and commercializes new fertility treatments.

Recently, OvaScience Inc (NASDAQ:OVAS) conducted a public offering of 5.0 million shares of common stock at a price of $10.00 per share. The company will use the net proceed from the offering to fund OvaPrimeSM preclinical studies and the anticipated 2015 international launch, expand the AUGMENTSM international launch, establish an international subsidiary and for other general corporate purposes.

The underwriters of the public offering were granted a 30-day option to purchase up to an additional 750,000 shares of common stock of the company.

Last month, OvaScience posted its results for the fourth quarter and the fiscal year 2013. The net loss was 11.0 million, versus a net loss of $4.2 million in the fourth quarter of 2012. For the full year, the net loss amounted to $29.0 million, compared to $13.5 million in the previous year. The increase of the loss was due to a one-time charge of $4.7 million for a technology access fee, with respect to the company’s collaboration with Intrexon, and also due to the high personnel costs, which includes stock-based compensation.

In addition, during the last year, OvaScience Inc (NASDAQ:OVAS) issued $2.5 million of common stock to Intrexon under the collaboration agreement and the remainder will be paid in December 2014. There was also a rise in the research and development expense to $15.8 million in 2013, from $6.3 million in 2012.

Hal Mintz’s Sabby Capital is another hedge fund that is bullish on OvaScience Inc, which holds 152,336 shares, worth $1.4 million.

Last week, Christoph Westphal and Richard Aldrich, director at OvaScience Inc, purchased 100,000 shares. Michelle Dipp, President & CEO and Longwood Fund, L.p., a large shareholder of the company also purchased 100,000 shares each of OvaScience. All three insiders purchased the securities at the public offering price of $10.00 per share.

Deerfield Management focuses on healthcare companies and specializes in funding R&D, corporate transitions, managing hostile takeovers and financial advisory services.

Last month, Deerfield Management boosted its position in Auspex Pharmaceuticals Inc (NASDAQ:ASPX), by buying 700,000 shares and revealed owning 1.9 million shares of the company. The fund also added 350,000 shares of Cara Therapeutics Inc. (NASDAQ:CARA). The fund also added KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) to its equity portfolio, the previous month, and revealed holding 3.18 million shares of the company.

Disclosure: none

Recommended Readings:

Deerfield Management Further Raises Its Position in Auspex Pharmaceuticals Inc (ASPX)

Deerfield Management Adds Cara Therapeutics Inc. (CARA) To Its Equity Portfolio

Deerfield Management Reports New Stake in KaloBios Pharmaceuticals Inc (KBIO)

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!